A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation
Low physical stability is the limitation of the widespread use of amorphous drugs. The co-amorphous drug system is a new and emerging method for preparing a stable amorphous form. Co-amorphous is a single-phase amorphous multicomponent system consisting of two or more small molecules that are a comb...
Main Authors: | Ahmad Ainurofiq, Rachmat Mauludin, Diky Mudhakir, Sundani Nurono Soewandhi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/10/3/85 |
Similar Items
-
Development and validation of an improved LC-MS/MS method for the quantification of desloratadine and its metabolite in human plasma using deutrated desloratadine as internal standard
by: M Saquib Hasnain, et al.
Published: (2013-01-01) -
Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals
by: Alekhina Т.А., et al.
Published: (2017-04-01) -
Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals.
by: Т. А. Alekhina, et al.
Published: (2017-04-01) -
Identification of Candesartan Cilexetil-L-Arginine Co-amorphous Formation and Its Solubility Test
by: Fikri Alatas, et al.
Published: (2022-02-01) -
Efficacy of Desloratadine Treatment of Children with Allergic Rhinitis
by: R. M. Faizullina, et al.
Published: (2015-11-01)